Abstract:Even though existing chemotherapeutic agents, including paclitaxel (PTX), possess superior anticancer activity, their application is limited because of extreme hydrophobicity. Here, a dendrimer-based nanoparticles system has been prepared for improved delivery of loaded paclitaxel to the tumor. The cell-penetrating peptides, octa-arginine (R) and vitamin-E succinate (VES), had been conjugated to the PEGylated generation 4 polyamidoamine dendrimer (D) to form RVES-PD. The synthesized polymers had been characterized by 1NMR, IR, and gel permeation chromatography. The PTX-loaded RVES-PD (RVES-PD-PTX) was physicochemically characterized for particle size, zeta potential analysis, drug loading, release, and encapsulation studies. Cellular uptake, cytotoxicity, and apoptosis determination studies were carried out in human lung cancer cells (A549) in monolayers and spheroids. In vivo antitumor efficacy of RVES-PD-PTX was determined using B16F10 tumor-bearing mice. The results indicated that the RVES-PD nanoparticles were taken up by cancer cells effectively and demonstrated improved cellular translocation compared to nontargeted VES-PD. The cytotoxicity study revealed that RVES-PD-PTX exhibited the highest cytotoxicity of PTX compared to nontargeted VES-PD-PTX and free PTX in the PTX concentration range of 0-50 μg/mL. RVES-PD-PTX-induced apoptosis as analyzed by the Annexin V assay and suppressed the growth of spheroids to the highest extent compared to VES-PD-PTX and free PTX. Furthermore, the biodistribution study indicated that the RVES-PD had higher accumulation in tumor compared to VES-PD. The in vivo experiment using B16F10 tumor-bearing mice demonstrated that the RVES-PD treatment resulted in the highest rate of tumor volume reduction and apoptosis primarily by upregulating caspase 3/7 to the highest extent compared to VES-PD and free PTX. In conclusion, the developed RVES-PD could load PTX and showed efficient cell penetration and improved PTX-mediated cytotoxicity in all tested in vitro and in vivo assay systems. The results strongly suggest further exploration of this developed PTX-nanoformulation in cancer treatment.

Electrospun polydioxanone/fucoidan blend nanofibers loaded with anti-cancer precipitate from Jaspis diastra and paclitaxel: Physico-chemical characterization and in-vitro screening

Bio-responsive Bletilla Striata Polysaccharide-Based Micelles for Enhancing Intracellular Docetaxel Delivery

Interactions of Self-Assembled Bletilla S triata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles.

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Electrospun self-emulsifying core-shell nanofibers for effective delivery of paclitaxel

Paclitaxel-Loaded Silk Fibroin Nanospheres

Electrospun Poly-lactic Acid/Chitosan Nanofibers Loaded with Paclitaxel for Coating of a Prototype Polymeric Stent

Facile Preparation of Paclitaxel Loaded Silk Fibroin Nanoparticles for Enhanced Antitumor Efficacy by Locoregional Drug Delivery

Biodegradable Electrospun Polyester-Urethane Nanofiber Scaffold: Codelivery Investigation of Doxorubicin-Ezetimibe and Its Synergistic Effect on Prostate Cancer Cell Line

Electrospun Poly(L-Lactide) Nanofibers Loaded with Paclitaxel and Water-Soluble Fullerenes for Drug Delivery and Bioimaging

Uniform Block Copolymer Nanofibers for the Delivery of Paclitaxel in 2D and 3D Glioblastoma Tumor Models

Nanofibers Embedded with Nanoparticles as Carriers for the Controlled Release of Anticancer Drug: Promoting the Apoptosis of Breast Cancer Cell Line and Growth Inhibition of Microbial Strains

Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence

Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles

Superior Antitumor Effect of Extremely High Drug Loading Self-Assembled Paclitaxel Nanofibers

Study on the Effect and Mechanism of Paclitaxel-Succini Acid Drug-Loaded Nanofibers in Treating Lung Cancer.

A Novel Electrospun Nanofiber System with PEGylated Paclitaxel Nanocrystals enhancing the Transmucus Permeability and in Situ Retention for an Efficient Cervicovaginal Cancer Therapy

Cell-Penetrating Peptide and α-Tocopherol-Conjugated Poly(amidoamine) Dendrimers for Improved Delivery and Anticancer Activity of Loaded Paclitaxel

Poly-alpha,beta-Polyasparthydrazide-Based Nanogels for Potential Oral Delivery of Paclitaxel: In Vitro and In Vivo Properties